EUVIMEDEUVIMED entdecken
Crossref

Postoperative Skeletal Muscle Relaxants and Risk of Periprosthetic Fracture After Total Hip Arthroplasty

Samuel Wertz, Peter Sells, Victor Shen, Jackson Durbin, Eric Cui, Ian Winthrop, Zoë Norris, Rachel Ranson, Robert Sterling

The Journal of Arthroplasty · 2026-11

DOI: 10.1016/j.arth.2026.11.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2026-11. Verfasst von Samuel Wertz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC. Electronic address: samue…. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Skeletal muscle relaxants (SMR) are often prescribed postoperatively following total hip arthroplasty (THA). These medications can increase fall risk by causing drowsiness and sedation. This study seeks to explore the association between postoperative SMR use and periprosthetic fracture (PPFx). We hypothesized that postoperative SMR use would be associated with increased odds of PPFx and that this association would be stronger among SMR-naive users. METHODS: A large national database was used to identify adult patients who underwent THA for either femoral head or neck fracture (FHNFx) or osteoarthritis (OA) from 2011 to 2025. Patients were stratified into two cohorts based on whether they were prescribed an SMR in the first postoperative month. Patients who were not prescribed a postoperative SMR served as controls. The experimental cohort was further stratified into naive or chronic SMR users based on the absence or presence of an SMR prescription within six months prior to surgery. The primary outcomes were 30-day odds of PPFx and reoperation. RESULTS: Both naive and chronic postoperative SMR use were associated with increased 30-day odds of PPFx following THA in FHNFx patients (naive: odds ratio (OR) 2.36, 95% confidence interval (CI) [1.17 to 4.83], P = 0.013; chronic: OR 2.75, 95% CI [1.48 to 5.08], P = 0.001) and OA patients (naive: OR 8.06, 95% CI [5.39 to 12.03]; chronic: OR 4.41, 95% CI [2.68 to 7.26]; P < 0.001 for both). DISCUSSION: Prescription of SMR after THA is associated with greater 30-day odds of PPFx and reoperation following THA, with the strongest association observed in naive OA patients. Surgeons should carefully weigh the risks and benefits of postoperative SMR use.

Schlagwörter

Stichwörter der Autor:innen

Total hip arthroplastyfall riskmuscle relaxantperiprosthetic fracture

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC. Electronic address: samuel.wertz@gwmail.gwu.edu.
  • Campbell University School of Osteopathic Medicine, Lillington, NC.
  • Department of Orthopaedic Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC.

Zitieren

APA

Wertz, S., Sells, P., Shen, V., Durbin, J., Cui, E., Winthrop, I., Norris, Z., Ranson, R., & Sterling, R. (2026). Postoperative Skeletal Muscle Relaxants and Risk of Periprosthetic Fracture After Total Hip Arthroplasty. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2026.11.021

Vancouver

Wertz S, Sells P, Shen V, Durbin J, Cui E, Winthrop I, et al. Postoperative Skeletal Muscle Relaxants and Risk of Periprosthetic Fracture After Total Hip Arthroplasty. The Journal of Arthroplasty. 2026. doi:10.1016/j.arth.2026.11.021

BibTeX
@article{Wertz2026,
  author = {Wertz, Samuel and Sells, Peter and Shen, Victor and Durbin, Jackson and Cui, Eric and Winthrop, Ian and Norris, Zoë and Ranson, Rachel and Sterling, Robert},
  title = {Postoperative Skeletal Muscle Relaxants and Risk of Periprosthetic Fracture After Total Hip Arthroplasty},
  journal = {The Journal of Arthroplasty},
  year = {2026},
  doi = {10.1016/j.arth.2026.11.021}
}
Kostenlos starten →